RubrYc Therapeutics

OverviewSuggest Edit

RubrYc Therapeutics is a biotechnology solutions company using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies. Inspired by recent advancements in molecular library synthesis, massively parallel screening and computing, the Company is forging a new path for information-driven discovery of therapeutic antibodies. Using its RubrYc Discovery Engine, the Company can decode protein interactions through the integration of data and biological science. This interface-targeted approach allows RubrYc to accelerate pre-clinical therapeutic antibody discovery, while minimizing many of the risks associated with current drug discovery paradigms.

TypePrivate
Founded2017
HQSan Ramon, CA, US
Websiterubryc.com

Latest Updates

Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

RubrYc Therapeutics Office Locations

RubrYc Therapeutics has offices in San Ramon and San Carlos
San Ramon, CA, US (HQ)
2420 Camino Ramon #125
San Carlos, CA, US
733 Industrial Rd
Show all (2)

RubrYc Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

RubrYc Therapeutics total Funding

$10 m

RubrYc Therapeutics latest funding size

$10 m

Time since last funding

4 years ago

RubrYc Therapeutics investors

RubrYc Therapeutics's latest funding round in April 2018 was reported to be $10 m. In total, RubrYc Therapeutics has raised $10 m
Show all financial metrics

RubrYc Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

RubrYc Therapeutics Online and Social Media Presence

Embed Graph

RubrYc Therapeutics News and Updates

RubrYc Therapeutics Announces formation of its Scientific Advisory Board

SAN CARLOS, Calif., Dec. 4, 2019 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical company developing therapeutic antibodies for the treatment of cancer and autoimmune diseases, today announced the creation of its Scientific Advisory Board (SAB) to support RubrYc's management...

RubrYc Therapeutics appoints Jean Viret, Ph.D. to its Board of Directors

SAN RAMON, Calif., Nov. 6, 2018 /PRNewswire/ -- RubrYc Therapeutics, a discovery-stage biotherapeutics company, today announced that Jean Viret, Ph.D. has been appointed to the company's Board of Directors. "I am thrilled to welcome Dr. Viret to our Board of Directors. Jean is an agile...

RubrYc Therapeutics Winner of the 2018 Xcelerate Startup Pitch Competition

BOSTON, Sept. 6, 2018 /PRNewswire/ -- RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it was selected the winner of the 2018 Xcelerate Startup Pitch Competition held September 5, 2018, as part of Biotech Week Boston. "I am honored to be recognized amongst...

RubrYc Therapeutics Frequently Asked Questions

  • When was RubrYc Therapeutics founded?

    RubrYc Therapeutics was founded in 2017.

  • Who are RubrYc Therapeutics competitors?

    Competitors of RubrYc Therapeutics include Evolution Research Group, Leinco Technologies and Reaction Biology.

  • Where is RubrYc Therapeutics headquarters?

    RubrYc Therapeutics headquarters is located at 2420 Camino Ramon #125, San Ramon.

  • Where are RubrYc Therapeutics offices?

    RubrYc Therapeutics has offices in San Ramon and San Carlos.

  • How many offices does RubrYc Therapeutics have?

    RubrYc Therapeutics has 2 offices.